StockData
BlossomHill Therapeutics, Inc. logo

BlossomHill Therapeutics, Inc. (BLSM) stock

BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$15.13+1.48 (+10.84%)

Close on Nov 17, 2026Market cap $38.56MP/E –Yield –

BlossomHill Therapeutics cash

Cash and short-term investments held at the end of each period.

BlossomHill Therapeutics's cash was $95.38M at Jun 30, 2026. For fiscal 2025 it was $136.68M, up 36.5% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$136.68M+36.5%
FY2024Dec 31, 2024$100.15M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$95.38M–
Q4 FY2025Dec 31, 2025$136.68M–
Q2 FY2025Jun 30, 2025$79.11M–
Q4 FY2024Dec 31, 2024$100.15M–

More BlossomHill Therapeutics figures

See a number that looks wrong?